Displaying 649 - 660 items out of 696 results
ILCN article
Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates
… Researchers say increased screening of at-risk populations, …
Resource
… your copy of Advances in Thoracic Oncology Treatment & Research: Legacy of Impact, Future of Promise. IASLC’s 50th …
Podcast
… on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a …
Podcast
… West interviewed Dr. Tony Mok about highlights and new research from the 2019 IASLC World Conference on Lung Cancer. …
Podcast
… on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the advancements in lung cancer research. To reach a global audience, IASLC has recorded …
Podcast
… cancer, accounting for 1.8 million deaths last year, yet research funding devoted to lung cancer pales in comparison to … this gap. His guest is Dr. Anne-Marie Baird, a cancer researcher at Trinity College in Dublin, Ireland. Dr. Baird is …
ILCN article
Oral Abstract Presentations to Focus on the Application of Multidisciplinary Care
… On Monday, August 8, four researchers will share data showing the benefits of …
ILCN article
World Conference Conversations: Inside WCLC 2025
… to reflect on the latest advances and cutting-edge research in thoracic oncology. Noemi Reguart, MD, PhD In early …
Podcast
… and what his hopes are for the future of lung cancer research. … Interview with IASLC President - Dr. Tetsuya …
Podcast
… and Dr. Amy Moore, a trained virologist and cancer researcher. Dr. Bunn is the founding director of the … and ASCO. Dr. Moore serves as the director of Science and Research for the GO2 Foundation for Lung Cancer. Together, …
ILCN article
When Perfect is the Enemy of Good: Investigators Compare Rigorous Clinical Trial Data to Real-World Experience
… Using a real-world cohort of US veterans, researchers examine the effectiveness of durvalumab …
ILCN article
Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study
… combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced …